Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 22, 1997

View Archived Issues

Squalamine enters phase I for the treatment of cancer

Flt3 ligand stimulates production of fully functional dendritic cells

Penederm and Mylan to copromote Mentax

Vyrex's respiratory antioxidant shows potential as asthma therapy

Idec's immunotherapy shows promise in phase I/II for non-Hodgkin's lymphoma

Prevention of neurodegeneration in Parkinson's disease reported

Peptidomimetic inhibitors of protein farnesyltransferase from Merck & Co.

HGS discloses new cysteine protease inhibitor

In vitro and in vivo immunosuppressive effects of FTY-720

Pharmacological characterization of LY-344864, a selective 5-HT1F receptor agonist

New antiviral agent for flu disclosed in patent literature

Novel nicotinic ligand discovered by British university researchers

Isolation, structural elucidation and preliminary biological evaluation of new XOD inhibitor

Gensia pursues formation of Metabasis as separate company and announces Sankyo investment

Antibody-based therapeutics alliance formed by CAT and Icos

Schering-Plough obtains rights to Claritin metabolite from Sepracor

New antitumor agent in development in China

VasoCare therapy successfully completes E.U. regulatory approval audit

Cel-Sci and NCI to test L.E.A.P.S. in NCI animal models of cancer

ICI-182780 associated with longer remission duration than megestrol in resistant breast cancer

Life Medical Sciences terminates Piliel trials early; refocuses R&D efforts

CY-1503 reduces reperfusion injury in a dog lung allograft model

Boehringer Ingelheim and Thomae to operate as one legal entity

FDA clears Trovan, Pfizer's broad-spectrum quinolone

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...